CJC-1295 DAC Nasal Spray

CJC-1295 DAC Nasal Spray is a research-grade synthetic peptide analogue of growth hormone-releasing hormone (GHRH), enhanced with a Drug Affinity Complex (DAC) to extend its half-life and bioavailability in laboratory settings. Supplied by Direct Anti Peptide at ≥98% purity, this compound is intended solely for qualified researchers and laboratory professionals investigating growth hormone axis biology. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

CJC-1295 DAC Nasal Spray is a modified GHRH peptide analogue in which the Drug Affinity Complex technology enables covalent binding to endogenous albumin, dramatically prolonging circulating half-life compared to unmodified GHRH analogues. The nasal spray delivery format has attracted significant scientific interest as a non-invasive administration route suitable for controlled research protocols. Available from Direct Anti Peptide in both 15 ml and 30 ml bottle formats, this compound is positioned as a premium research tool for studies examining growth hormone secretion, metabolic signalling, and related physiological pathways.

Peptide Structure & Amino Acid Sequence

CJC-1295 DAC is a 30-amino acid synthetic peptide derived from the first 29 residues of endogenous GHRH, with a C-terminal modification incorporating the Drug Affinity Complex (DAC) moiety. This structural modification facilitates covalent attachment to serum albumin via a reactive maleimidoproprionic acid (MPA) linker, conferring extended plasma stability. The resulting peptide retains full agonist activity at the GHRH receptor (GHRHR), making it a scientifically valuable tool for in-vitro receptor binding studies and ex-vivo tissue research.

Chemical & Physical Characteristics

• Peptide Name: CJC-1295 with Drug Affinity Complex (DAC)
• Molecular Formula: C₁₅₂H₂₅₂N₄₂O₄₂
• Molecular Weight: Approximately 3647.3 g/mol
• Appearance: Lyophilised white to off-white powder, reconstituted into nasal spray solution
• Delivery Format: Nasal spray solution (15 ml and 30 ml)
• Solubility: Soluble in aqueous buffered solutions
• Storage Temperature: 2–8°C (refrigerated); protect from light and moisture

Purity & Analytical Verification (HPLC & MS)

Every batch of CJC-1295 DAC Nasal Spray supplied by Direct Anti Peptide undergoes rigorous analytical testing to confirm a minimum purity of ≥98%. High-Performance Liquid Chromatography (HPLC) is employed to quantify peptide purity and detect any extraneous impurities or degradation products. Mass Spectrometry (MS) analysis verifies the precise molecular weight and confirms structural integrity, ensuring that the compound delivered to your laboratory is analytically authenticated and research-ready. Certificates of Analysis (CoA) are available upon request for full batch traceability.

Quality Control & Lyophilisation Integrity

Prior to formulation into the nasal spray matrix, the CJC-1295 DAC peptide is produced under stringent quality control conditions. Lyophilisation processes are validated to preserve peptide conformation and biological activity throughout storage and transit. The nasal spray solution is prepared under controlled conditions to ensure homogeneity, correct concentration, and long-term stability within the stated storage parameters. Direct Anti Peptide maintains comprehensive quality management protocols to support reproducible, reliable research outcomes.

Safety, Handling & Laboratory Precautions

CJC-1295 DAC Nasal Spray is a potent research compound and must be handled exclusively by trained laboratory professionals in appropriately equipped research facilities. Standard laboratory personal protective equipment (PPE) — including gloves, eye protection, and lab coat — should be worn at all times when handling this material. The compound must not be used on or administered to humans or animals under any circumstances. Researchers should consult the relevant Safety Data Sheet (SDS) before handling and ensure compliance with all applicable institutional and regulatory guidelines governing research peptides.

Reconstitution, Packaging & Storage

CJC-1295 DAC Nasal Spray is supplied pre-formulated in sterile nasal spray bottles of 15 ml and 30 ml. Products should be stored at 2–8°C in a refrigerated environment, protected from direct light and humidity. Once opened, bottles should be used within the timeframe specified on the product label to maintain integrity. All packaging is designed to preserve compound stability during shipping and storage. Researchers should adhere strictly to the storage and handling conditions outlined in the accompanying documentation.

Intended Research Use & Market Positioning

CJC-1295 DAC Nasal Spray is positioned as a premium research-grade peptide tool for scientists investigating growth hormone-releasing hormone receptor pharmacology, growth hormone secretion dynamics, metabolic regulation, lean tissue biology, sleep physiology, and immune modulation pathways. The nasal spray format is of particular interest to researchers exploring non-invasive peptide delivery mechanisms and subject compliance models in preclinical study design. This compound is not approved for therapeutic, clinical, diagnostic, or any consumptive use.

Ordering, Availability & Fulfillment

Direct Anti Peptide offers CJC-1295 DAC Nasal Spray for sale online with competitive pricing, reliable stock availability, and prompt order fulfillment. Researchers can buy online with confidence, knowing that every order is backed by our quality assurance standards and analytical documentation. Order now to benefit from our best price guarantee, fast dispatch, and secure packaging designed to maintain product integrity throughout delivery. Bulk ordering options and volume pricing may be available — contact our team for further details.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 DAC Nasal Spray is sold exclusively as a laboratory research reagent. Direct Anti Peptide makes no claims regarding therapeutic efficacy, safety for administration, or suitability for any use beyond controlled scientific research. Purchasers are solely responsible for ensuring that their acquisition, possession, and use of this compound complies with all applicable local, national, and international laws and regulations. This product must only be handled by qualified research professionals in authorised laboratory settings.